TRINITY BIOTECH PLC (TRIB) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
TRIB currently has 405M outstanding shares. with significant dilution risk as 4.33B authorized shares could dilute existing holders by 1068.4%. The company has significantly diluted shareholders by 108.52% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 13, 2026 |
F-3 filing: This filing involves the registration of up to 167,950,998 ADSs, representing 3,359,019,957 Ordinary Shares, to be offered for resale by selling shareholders upon the potential conversion of conversion obligations. |
410M | 4.3B |
| May 13, 2026 |
F-3 filing: The company is registering 33,752,429 ADSs to be sold by a selling securityholder and establishing a framework for potential future sales of ADSs to said securityholder under a purchase agreement for up to $25 million in gross proceeds. |
410M | 970M |
| Apr 30, 2026 |
20-F filing | 374.2M shares outstanding |
370M | 1B |
| Jan 15, 2026 |
F-1 filing: This F-1 filing indicates an offering of ADSs by a selling shareholder. The company will not receive any proceeds from the sale of the ADSs. |
370M | 1B |
| May 16, 2025 |
20-F filing | 359.2M shares outstanding |
360M | 0 |
| Mar 21, 2025 |
F-3 filing: This is an F-3 filing related to the indemnification of directors and officers, exhibits, undertakings, and includes information on ADSs offered by a selling shareholder, A Ordinary Shares outstanding, use of proceeds, and risk factors. |
380M | 0 |
| Nov 15, 2024 |
F-3 filing: This F-3 filing from 2024-11-15 relates to a shelf offering of 650,000 ADSs, with each ADS representing 20 A Ordinary Shares. The selling shareholder is offering these ADSs, and the company will not receive any proceeds from the sale. As of November 14, 2024, there were 357,005,182 A Ordinary Shares outstanding. |
360M | 0 |
| Jun 21, 2024 |
F-3 filing: The company filed an F-3 form to offer A Ordinary Shares, warrants to purchase A Ordinary Shares, debt securities (including convertible debt securities), and subscription rights up to $50,000,000. |
190M | 49M |
| Apr 30, 2024 |
20-F filing | 153.3M shares outstanding |
150M | 85M |
| Apr 30, 2024 |
F-3 filing: This is an F-3 filing for the registration of ADSs offered by the selling shareholder. |
190M | 49M |
| May 16, 2023 |
20-F filing | 152.4M shares outstanding |
150M | 30M |
| Mar 23, 2023 |
POS AM filing: This is a POS AM filing related to the offering of ADSs by a selling shareholder. |
150M | 29M |
| Aug 30, 2022 |
F-3 filing: This is an F-3 filing related to the offering of ADSs by a selling shareholder. The company will not receive any proceeds from the sale. The filing includes information about indemnification of directors and officers, exhibits, and undertakings. |
150M | 32M |
| May 16, 2022 |
F-3 filing: This F-3 filing includes information about indemnification of directors and officers, exhibits, and undertakings. It also mentions an offering of 2,500,000 ADSs by a selling shareholder and the potential receipt of up to $3,250,000 from warrant exercises. |
150M | 21M |
| May 02, 2022 |
20-F filing | 83.6M shares outstanding |
84M | 87M |
| Apr 30, 2021 |
20-F filing | 83.6M shares outstanding |
84M | 87M |
| Jul 06, 2020 |
F-3 filing: The company is filing an F-3 form to offer 'A' Ordinary Shares, warrants, debt securities, subscription rights, or any combination of these, up to a total of $200,000,000. |
84M | 87M |
| Jun 15, 2020 |
20-F filing | 83.6M shares outstanding |
84M | 0 |